BIS Research - Emerging Technology Market Intelligence

Next Generation Sequencing Expanding to Pharmaceuticals, Diagnostics and Other Fields in the Healthcare Industry

Dec 11, 2017 5:30:30 AM / by BIS Research posted in nanopore sequencing, next gen sequencing, next generation sequencing services market, Reversible Terminator Sequencing, Global Next Generation Sequencing (NGS) Market, global ngs market share, Healthcare & Medical, Global Next Generation Sequencing, Global Next Generation Sequencing Market Revenue, Global Next Generation Sequencing Market Share, Ion Torrent Semiconductor Sequencing, ion torrent sequencing, next generation sequencing, next generation sequencing market, next generation sequencing market growth, next generation sequencing market report, next generation sequencing market size, NGS Market, ngs market share, ngs report, Single Molecule Real Time Sequencing

0 Comments

Over the last decade, advancements in sequencing chemistry, molecular biology, and biotechnology have transformed the sequencing field, by increasing its efficiency and decreasing the cost. The sequencing technology, called Sanger sequencing, used for the sequencing of first human genome took around 15 years to develop and cost approximately $2.7 billion. Since then, there has been an impressive progress in the fields of molecular biology and biotechnology, which have paved the way for Next Generation Sequencing (NGS), which is massively parallel and provides high throughput sequencing. NGS technology allows sequencing of millions of fragments at a time as opposed to Sanger sequencing, which in turn saves time and cost every session. At present, the cost of sequencing is $1000, which was brought down from $10 million earlier, and with the ongoing progress in sequencing technology, researchers are targeting to bring down the cost to $100 in the coming future.

Read More

Subscribe to Email Updates

Lists by Topic

see all

Have Questions? Schedule a Call